ALNY - Alnylam Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts16161615
Avg. Estimate-1.86-2.13-8.22-7.27
Low Estimate-2.41-2.52-9.49-8.8
High Estimate1.59-1.69-4.82-5.99
Year Ago EPS-1.63-2.43-7.57-8.22
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts15151817
Avg. Estimate69.2M51.96M211.55M428.75M
Low Estimate30M35M139.2M321M
High Estimate446.6M89.83M590.2M592.61M
Year Ago Sales29.91M17.99M74.91M211.55M
Sales Growth (year/est)131.40%188.80%182.40%102.70%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-1.75-1.99-2.21-2.07
EPS Actual-1.63-2.43-2.09-1.73
Difference0.12-0.440.120.34
Surprise %6.90%-22.10%5.40%16.40%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.86-2.13-8.22-7.27
7 Days Ago-1.86-2.13-8.22-7.27
30 Days Ago-1.85-2.11-8.17-7.28
60 Days Ago-1.87-2.13-8.17-7.09
90 Days Ago-2.07-2.06-8.5-6.85
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesALNYIndustrySectorS&P 500
Current Qtr.-14.10%N/AN/A0.01
Next Qtr.12.30%N/AN/A0.03
Current Year-8.60%N/AN/A0.04
Next Year11.60%N/AN/A0.10
Next 5 Years (per annum)46.09%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A